Remdesivir for the treatment of Covid-19—preliminary report JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ... New England Journal of Medicine 383 (19), 1813-1836, 2020 | 2685 | 2020 |
Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit EP Raith, AA Udy, M Bailey, S McGloughlin, C MacIsaac, R Bellomo, ... Jama 317 (3), 290-300, 2017 | 1217 | 2017 |
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper# MH Abdul-Aziz, JWC Alffenaar, M Bassetti, H Bracht, G Dimopoulos, ... Intensive care medicine 46, 1127-1153, 2020 | 753 | 2020 |
Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock: the VITAMINS … T Fujii, N Luethi, PJ Young, DR Frei, GM Eastwood, CJ French, AM Deane, ... Jama 323 (5), 423-431, 2020 | 485 | 2020 |
Subtherapeutic initial β-lactam concentrations in select critically ill patients AA Udy, JM Varghese, M Altukroni, S Briscoe, BC McWhinney, ... Chest 142 (1), 30-39, 2012 | 478 | 2012 |
Augmented renal clearance: implications for antibacterial dosing in the critically ill AA Udy, JA Roberts, RJ Boots, DL Paterson, J Lipman Clinical pharmacokinetics 49, 1-16, 2010 | 431 | 2010 |
Sensitivity to fungal allergens is a risk factor for life‐threatening asthma PN Black, AA Udy, SM Brodie Allergy 55 (5), 501-504, 2000 | 415 | 2000 |
Augmented renal clearance in the ICU: results of a multicenter observational study of renal function in critically ill patients with normal plasma creatinine concentrations AA Udy, JP Baptista, NL Lim, GM Joynt, P Jarrett, L Wockner, RJ Boots, ... Critical care medicine 42 (3), 520-527, 2014 | 307 | 2014 |
Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens JA Roberts, FS Taccone, AA Udy, JL Vincent, F Jacobs, J Lipman Antimicrobial agents and chemotherapy 55 (6), 2704-2709, 2011 | 271 | 2011 |
Clinical implications of antibiotic pharmacokinetic principles in the critically ill AA Udy, JA Roberts, J Lipman Intensive care medicine 39, 2070-2082, 2013 | 269 | 2013 |
Australian and New Zealand Intensive Care Society (ANZICS) Centre for Outcomes and Resource Evaluation (CORE). Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA … EP Raith, AA Udy, M Bailey, S McGloughlin, C MacIsaac, R Bellomo, ... Jama 317 (3), 290-300, 2017 | 251 | 2017 |
Implications of augmented renal clearance in critically ill patients AA Udy, JA Roberts, J Lipman Nature Reviews Nephrology 7 (9), 539-543, 2011 | 236 | 2011 |
A comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearance JP Baptista, AA Udy, E Sousa, J Pimentel, L Wang, JA Roberts, J Lipman Critical care 15, 1-8, 2011 | 228 | 2011 |
Augmented renal clearance in septic and traumatized patients with normal plasma creatinine concentrations: identifying at-risk patients AA Udy, JA Roberts, AF Shorr, RJ Boots, J Lipman Critical Care 17, 1-9, 2013 | 216 | 2013 |
Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 208 | 2021 |
Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients JJ De Waele, J Lipman, M Akova, M Bassetti, G Dimopoulos, M Kaukonen, ... Intensive care medicine 40, 1340-1351, 2014 | 203 | 2014 |
Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method P Nasa, E Azoulay, AK Khanna, R Jain, S Gupta, Y Javeri, D Juneja, ... Critical Care 25, 1-17, 2021 | 179 | 2021 |
The impact of disability in survivors of critical illness CL Hodgson, AA Udy, M Bailey, J Barrett, R Bellomo, T Bucknall, ... Intensive care medicine 43, 992-1001, 2017 | 172 | 2017 |
Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance? AA Udy, J Lipman, P Jarrett, K Klein, SC Wallis, K Patel, CMJ Kirkpatrick, ... Critical Care 19, 1-9, 2015 | 159 | 2015 |
Augmented renal clearance in critically ill patients: etiology, definition and implications for beta-lactam dose optimization FB Sime, AA Udy, JA Roberts Current opinion in pharmacology 24, 1-6, 2015 | 152 | 2015 |